Improving Acute Stroke Management with Computed Tomography Perfusion: A Review of Imaging Basics and Applications

Translational Stroke Research

Volumn 3, Issue 2, 2012, Pages 205-220

  d'Esterre, C D ^a   Fainardi, Enrico ^b   Aviv, R I ^c   Lee, T Y ^a,d  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b UNIVERSITY HOSPITAL OF FERRARA   (Italy)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^d ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

Acute stroke; Cerebral blood flow; Cerebral blood volume; Computed tomography perfusion; Hemorrhagic transformation; Permeability surface area product; Primary hemorrhage

Indexed keywords

NICARDIPINE; TISSUE PLASMINOGEN ACTIVATOR; VASODILATOR AGENT;

BLEEDING; BLOOD BRAIN BARRIER; BLOOD CLOT LYSIS; BRAIN ISCHEMIA; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTED TOMOGRAPHY PERFUSION; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DISEASE SEVERITY; HUMAN; HYPEREMIA; IONIZING RADIATION; MATHEMATICAL MODEL; PERFUSION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; STROKE; STROKE PATIENT; SUBARACHNOID HEMORRHAGE; TIME TO MAXIMUM PLASMA CONCENTRATION;

EID: 84861705726     PISSN: 18684483     EISSN: 1868601X     Source Type: Journal    
DOI: 10.1007/s12975-012-0178-5     Document Type: Review

References (135)

1. Kleindorfer DO, Khoury J, Moomaw CJ, et al. Stroke incidence is decreasing in Whites but not in Blacks: a population-based estimate of temporal trends in stroke incidence from the Greater Cincinnati/Northern Kentucky Stroke Study. Stroke. 2010; 41(7): 1326-31.
2. Carandang R, Seshadri S, Beiser A, et al. Trends in incidence, lifetime risk, severity, and 30-day mortality of stroke over the past 50 years. JAMA. 2006; 296(24): 2939-46.
3. Xian Y, Holloway RG, Noyes K, Shah MN, Friedman B. Racial differences in mortality among patients with acute ischemic stroke: an observational study. Ann Intern Med. 2011; 154(3): 152-9. Feb 1.
4. Mohan KM, Crichton SL, Grieve AP, Rudd AG, Wolfe CD, Heuschmann PU. Frequency and predictors for the risk of stroke recurrence up to 10 years after stroke: the South London Stroke Register. J Neurol Neurosurg Psychiatry. 2009; 80(9): 1012-8.
5. Minino A. Deaths: final data for 2008. Natl Vital Stat Rep. 2011; 59(10): 1-2.
6. Wintermark M, Albers GW, Alexandrov AV, et al. Acute stroke imaging research roadmap. AJNR Am J Neuroradiol. 2008; 29(5): e23-30.
7. Aviv RI, d'Esterre CD, Murphy BD, et al. Hemorrhagic transformation of ischemic stroke: prediction with CT perfusion. Radiology. 2009; 250(3): 867-77.
8. Lee TY. Functional CT: physiological models. Trends in Biotechnology. 2002; 20(8): suppl.
9. Konstas AA, Goldmakher GV, Lee TY, Lev MH. Theoretic basis and technical implementations of CT perfusion in acute ischemic stroke, part 2: technical implementations. AJNR Am J Neuroradiol. 2009; 30(5): 885-92.
10. Nabavi DG, Cenic A, Henderson S, Gelb AW, Lee TY. Perfusion mapping using computed tomography allows accurate prediction of cerebral infarction in experimental brain ischemia. Stroke. 2001; 32(1): 175-83.
11. Gamel J, Rousseau WF, Katholi CR, Mesel E. Pitfalls in digital computation of the impulse response of vascular beds from indicator-dilution curves. Circ Res. 1973; 32(4): 516-23.
12. Cenic A, Nabavi DG, Craen RA, Gelb AW, Lee TY. Dynamic CT measurement of cerebral blood flow: a validation study. AJNR Am J Neuroradiol. 1999; 20(1): 63-73.
13. Lee TY, Purdie TG, Stewart E. CT imaging of angiogenesis. Q J Nucl Med. 2003; 47(3): 171-87.
14. Groothuis DR, Vriesendorp FJ, Kupfer B, et al. Quantitative measurements of capillary transport in human brain tumors by computed tomography. Ann Neurol. 1991; 30(4): 581-8.
15. Yeung WT, Lee TY, Del Maestro RF, Kozak R, Brown T. In vivo CT measurement of blood-brain transfer constant of iopamidol in human brain tumors. J Neurooncol. 1992; 14(2): 177-87.
16. Patlak CS, Blasberg RG. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations. J Cereb Blood Flow Metab. 1985; 5(4): 584-90.
17. St Lawrence KS, Lee TY. An adiabatic approximation to the tissue homogeneity model for water exchange in the brain: I. Theoretical derivation. J Cereb Blood Flow Metab. 1998; 18(12): 1365-77.
18. St Lawrence KS, Lee TY. An adiabatic approximation to the tissue homogeneity model for water exchange in the brain: II. Experimental validation. J Cereb Blood Flow Metab. 1998; 18(12): 1378-85.
19. Nabavi DG, Cenic A, Dool J, et al. Quantitative assessment of cerebral hemodynamics using CT: stability, accuracy, and precision studies in dogs. J Comput Assist Tomogr. 1999; 23(4): 506-15. Jul-Aug.
20. Furukawa M, Kashiwagi S, Matsunaga N, Suzuki M, Kishimoto K, Shirao S. Evaluation of cerebral perfusion parameters measured by perfusion CT in chronic cerebral ischemia: comparison with xenon CT. J Comput Assist Tomogr. 2002; 26(2): 272-8. Mar-Apr.
21. Eastwood JD, Lev MH, Wintermark M, et al. Correlation of early dynamic CT perfusion imaging with whole-brain MR diffusion and perfusion imaging in acute hemispheric stroke. AJNR Am J Neuroradiol. 2003; 24(9): 1869-75.
22. Gillard JH, Antoun NM, Burnet NG, Pickard JD. Reproducibility of quantitative CT perfusion imaging. Br J Radiol. 2001; 74(882): 552-5.
23. 2(15)O positron emission tomography. AJNR Am J Neuroradiol. 2003; 24(3): 419-26.
24. Wintermark M, Thiran JP, Maeder P, Schnyder P, Meuli R. Simultaneous measurement of regional cerebral blood flow by perfusion CT and stable xenon CT: a validation study. AJNR Am J Neuroradiol. 2001; 22(5): 905-14.
25. Miles KA, Griffiths MR. Perfusion CT: a worthwhile enhancement? Br J Radiol. 2003; 76(904): 220-31.
26. Abels B, Klotz E, Tomandl BF, Kloska SP, Lell MM. Perfusion CT in acute ischemic stroke: a qualitative and quantitative comparison of deconvolution and maximum slope approach. AJNR Am J Neuroradiol. Oct; 31(9): 1690-1698.
27. Wintermark M, Smith WS, Ko NU, Quist M, Schnyder P, Dillon WP. Dynamic perfusion CT: optimizing the temporal resolution and contrast volume for calculation of perfusion CT parameters in stroke patients. AJNR Am J Neuroradiol. 2004; 25(5): 720-9.
28. Wintermark M, Reichhart M, Thiran JP, et al. Prognostic accuracy of cerebral blood flow measurement by perfusion computed tomography, at the time of emergency room admission, in acute stroke patients. Ann Neurol. 2002; 51(4): 417-32.
29. Lencioni R, Fattori R, Morana G, Stacul F. Contrast-induced nephropathy in patients undergoing computed tomography (CONNECT)-a clinical problem in daily practice? A multicenter observational study. Acta Radiol. Sep; 51(7): 741-750.
30. d'Esterre CD, Chia TL, Jairath A, Lee TY, Symons SP, Aviv RI. Early rate of contrast extravasation in patients with intracerebral hemorrhage. AJNR Am J Neuroradiol. Nov-Dec; 32(10): 1879-1884.
31. Hom J, Dankbaar JW, Soares BP, et al. Blood-brain barrier permeability assessed by perfusion CT predicts symptomatic hemorrhagic transformation and malignant edema in acute ischemic stroke. AJNR Am J Neuroradiol. Jan; 32(1): 41-48.
32. Wintermark M, Albers GW, Alexandrov AV, et al. Acute stroke imaging research roadmap. Stroke. 2008; 39(5): 1621-8.
33. Frey GD, Rumboldt Z. Radiation effects from perfusion CT. Radiology. 2005; 234(2): 638. author reply 638.
34. Rapalino O, Kamalian S, Payabvash S, et al. Cranial CT with adaptive statistical iterative reconstruction: improved image quality with concomitant radiation dose reduction. AJNR Am J Neuroradiol. Jan 19 (epub ahead of print).
35. Wu O, Ostergaard L, Koroshetz WJ, et al. Effects of tracer arrival time on flow estimates in MR perfusion-weighted imaging. Magn Reson Med. 2003; 50(4): 856-64.
36. Wu O, Ostergaard L, Weisskoff RM, Benner T, Rosen BR, Sorensen AG. Tracer arrival timing-insensitive technique for estimating flow in MR perfusion-weighted imaging using singular value decomposition with a block-circulant deconvolution matrix. Magn Reson Med. 2003; 50(1): 164-74.
37. Willats L, Connelly A, Calamante F. Minimising the effects of bolus dispersion in bolus-tracking MRI. NMR Biomed. 2008; 21(10): 1126-37.
38. Sanelli PC, Lev MH, Eastwood JD, Gonzalez RG, Lee TY. The effect of varying user-selected input parameters on quantitative values in CT perfusion maps. Acad Radiol. 2004; 11(10): 1085-92.
39. Ferreira RM, Lev MH, Goldmakher GV, et al. Arterial input function placement for accurate CT perfusion map construction in acute stroke. AJR Am J Roentgenol. May; 194(5): 1330-1336.
40. Wahlgren N, Ahmed N, Davalos A, et al. Thrombolysis with alteplase 3-4. 5 h after acute ischaemic stroke (SITS-ISTR): an observational study. Lancet. 2008; 372(9646): 1303-9.
41. Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA. 1995; 274(13): 1017-25. Oct 4.
42. Schumacher HC, Bateman BT, Boden-Albala B, et al. Use of thrombolysis in acute ischemic stroke: analysis of the Nationwide Inpatient Sample 1999 to 2004. Ann Emerg Med. 2007; 50(2): 99-107.
43. Fang MC, Cutler DM, Rosen AB. Trends in thrombolytic use for ischemic stroke in the United States. J Hosp Med. 2010; 5(7): 406-9.
44. Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4. 5 hours after acute ischemic stroke. N Engl J Med. 2008; 359(13): 1317-29.
45. Bluhmki E, Chamorro A, Davalos A, et al. Stroke treatment with alteplase given 3. 0-4. 5 h after onset of acute ischaemic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trial. Lancet Neurol. 2009; 8(12): 1095-102.
46. Shobha N, Buchan AM, Hill MD. Thrombolysis at 3-4. 5 hours after acute ischemic stroke onset-evidence from the Canadian Alteplase for Stroke Effectiveness Study (CASES) Registry. Cerebrovasc Dis. 2011; 31(3): 223-8. Dec 21.
47. Gobin YP, Starkman S, Duckwiler GR, et al. MERCI 1: a phase 1 study of mechanical embolus removal in cerebral ischemia. Stroke. 2004; 35(12): 2848-54.
48. Tenser MS, Amar AP, Mack WJ. Mechanical thrombectomy for acute ischemic stroke using the MERCI retriever and penumbra aspiration systems. World Neurosurg. Dec; 76(6 Suppl): S16-23.
49. Baker WL, Colby JA, Tongbram V, et al. Neurothrombectomy devices for the treatment of acute ischemic stroke: state of the evidence. Ann Intern Med. Feb 15; 154(4): 243-252.
50. Larrue V, von Kummer RR, Muller A, Bluhmki E. Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II). Stroke. 2001; 32(2): 438-41.
51. Albers GW, Thijs VN, Wechsler L, et al. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol. 2006; 60(5): 508-17.
52. Bandera E, Botteri M, Minelli C, Sutton A, Abrams KR, Latronico N. Cerebral blood flow threshold of ischemic penumbra and infarct core in acute ischemic stroke: a systematic review. Stroke. 2006; 37(5): 1334-9.
53. Ebinger M, De Silva DA, Christensen S, et al. Imaging the penumbra-strategies to detect tissue at risk after ischemic stroke. J Clin Neurosci. 2009; 16(2): 178-87.
54. Hatazawa J, Shimosegawa E, Toyoshima H, et al. Cerebral blood volume in acute brain infarction: a combined study with dynamic susceptibility contrast MRI and 99mTc-HMPAO-SPECT. Stroke. 1999; 30(4): 800-6.
55. Heiss WD, Sobesky J, Hesselmann V. Identifying thresholds for penumbra and irreversible tissue damage. Stroke. 2004; 35(11 Suppl 1): 2671-4.
56. Hjort N, Butcher K, Davis SM, et al. Magnetic resonance imaging criteria for thrombolysis in acute cerebral infarct. Stroke. 2005; 36(2): 388-97.
57. Rohl L, Ostergaard L, Simonsen CZ, et al. Viability thresholds of ischemic penumbra of hyperacute stroke defined by perfusion-weighted MRI and apparent diffusion coefficient. Stroke. 2001; 32(5): 1140-6.
58. Zaro-Weber O, Moeller-Hartmann W, Heiss WD, Sobesky J. The performance of MRI-based cerebral blood flow measurements in acute and subacute stroke compared with 15O-water positron emission tomography. Identification of penumbral flow. Stroke. 40: 2413-2421.
59. Kalafut MA, Schriger DL, Saver JL, Starkman S. Detection of early CT signs of > 1/3 middle cerebral artery infarctions: interrater reliability and sensitivity of CT interpretation by physicians involved in acute stroke care. Stroke. 2000; 31(7): 1667-71.
60. Pexman JH, Barber PA, Hill MD, et al. Use of the Alberta Stroke Program Early CT Score (ASPECTS) for assessing CT scans in patients with acute stroke. AJNR Am J Neuroradiol. 2001; 22(8): 1534-42.
61. Barber PA, Demchuk AM, Zhang J, Buchan AM. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. Lancet. 2000; 355(9216): 1670-4.
62. Dzialowski I, Hill MD, Coutts SB, et al. Extent of early ischemic changes on computed tomography (CT) before thrombolysis: prognostic value of the Alberta Stroke Program Early CT Score in ECASS II. Stroke. 2006; 37(4): 973-8.
63. Sillanpaa N, Saarinen JT, Rusanen H, et al. The clot burden score, the Boston Acute Stroke Imaging Scale, the cerebral blood volume ASPECTS, and two novel imaging parameters in the prediction of clinical outcome of ischemic stroke patients receiving intravenous thrombolytic therapy. Neuroradiology. 2011 (Epub ahead of print).
64. Madden KP, Karanjia PN, Adams Jr HP. Clarke WR. Accuracy of initial stroke subtype diagnosis in the TOAST study. Trial of ORG 10172 in Acute Stroke Treatment. Neurology. 1995; 45(11): 1975-9.
65. Wardlaw JM, Dorman PJ, Lewis SC, Sandercock PA. Can stroke physicians and neuroradiologists identify signs of early cerebral infarction on CT? J Neurol Neurosurg Psychiatry. 1999; 67(5): 651-3.
66. al. NSe. CT perfusion ASPECTS in the evaluation of acute ischemic stroke: thrombolytic therapy perspective. Cerebrovascular Diseases. 2011; 1: 6-16.
67. Aviv RI, Mandelcorn J, Chakraborty S, et al. Alberta Stroke Program Early CT Scoring of CT perfusion in early stroke visualization and assessment. AJNR Am J Neuroradiol. 2007; 28(10): 1975-80. Nov-Dec.
68. Kim JT, Park MS, Choi KH, et al. The CBV-ASPECT Score as a predictor of fatal stroke in a hyperacute state. Eur Neurol. 63(6): 357-363.
69. Lin K, Rapalino O, Law M, Babb JS, Siller KA, Pramanik BK. Accuracy of the Alberta Stroke Program Early CT Score during the first 3 hours of middle cerebral artery stroke: comparison of noncontrast CT, CT angiography source images, and CT perfusion. AJNR Am J Neuroradiol. 2008; 29(5): 931-6.
70. Schramm P, Schellinger PD, Fiebach JB, et al. Comparison of CT and CT angiography source images with diffusion-weighted imaging in patients with acute stroke within 6 hours after onset. Stroke. 2002; 33(10): 2426-32.
71. Sharma M, Fox AJ, Symons S, Jairath A, Aviv RI. CT angiographic source images: flow- or volume-weighted? AJNR Am J Neuroradiol. Feb; 32(2): 359-364.
72. Hill MD, Coutts SB, Pexman JH, Demchuk AM. CTA source images in acute stroke. Stroke. 2003; 34(4): 835-7. author reply 835-837.
73. Schaefer PW, Roccatagliata L, Ledezma C, et al. First-pass quantitative CT perfusion identifies thresholds for salvageable penumbra in acute stroke patients treated with intra-arterial therapy. AJNR Am J Neuroradiol. 2006; 27(1): 20-5.
74. Simon JE, Bristow MS, Lu H, et al. A novel method to derive separate gray and white matter cerebral blood flow measures from MR imaging of acute ischemic stroke patients. J Cereb Blood Flow Metab. 2005; 25(9): 1236-43.
75. Murphy BD, Fox AJ, Lee DH, et al. White matter thresholds for ischemic penumbra and infarct core in patients with acute stroke: CT perfusion study. Radiology. 2008; 247(3): 818-25.
76. Murphy BD, Fox AJ, Lee DH, et al. Identification of penumbra and infarct in acute ischemic stroke using computed tomography perfusion-derived blood flow and blood volume measurements. Stroke. 2006; 37(7): 1771-7.
77. Schaefer PW, Mui K, Kamalian S, Nogueira RG, Gonzalez RG, Lev MH. Avoiding "pseudo-reversibility" of CT-CBV infarct core lesions in acute stroke patients after thrombolytic therapy. The need for algorithmically "delay-corrected" CT perfusion map postprocessing software. Stroke. Aug; 40(8): 2875-8.
78. Wintermark M, Flanders AE, Velthuis B, et al. Perfusion-CT assessment of infarct core and penumbra: receiver operating characteristic curve analysis in 130 patients suspected of acute hemispheric stroke. Stroke. 2006; 37(4): 979-85.
79. Sette G, Baron JC, Mazoyer B, Levasseur M, Pappata S, Crouzel C. Local brain haemodynamics and oxygen metabolism in cerebrovascular disease. Positron emission tomography. Brain. 1989; 112(Pt 4): 931-51.
80. Powers WJ, Grubb Jr RL, Raichle ME. Physiological responses to focal cerebral ischemia in humans. Ann Neurol. 1984; 16(5): 546-52.
81. Kidwell CS, Saver JL, Mattiello J, et al. Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging. Ann Neurol. 2000; 47(4): 462-9.
82. d'Esterre CD, Aviv RI, Lee TY. The evolution of the cerebral bood volume abnormality in patients with inschemic stroke: a CT perfusion study. Acta Radiol. 2012; in press.
83. Silvennoinen HM, Hamberg LM, Lindsberg PJ, Valanne L, Hunter GJ. CT perfusion identifies increased salvage of tissue in patients receiving intravenous recombinant tissue plasminogen activator within 3 hours of stroke onset. AJNR Am J Neuroradiol. 2008; 29(6): 1118-23.
84. Campbell BC, Christensen S, Levi CR, et al. Cerebral blood flow is the optimal CT perfusion parameter for assessing infarct core. Stroke. Dec; 42(12): 3435-3440.
85. Kamalian S, Maas MB, Goldmacher GV, et al. CT cerebral blood flow maps optimally correlate with admission diffusion-weighted imaging in acute stroke but thresholds vary by postprocessing platform. Stroke. Jul; 42(7): 1923-1928.
86. Marchal G, Young AR, Baron JC. Early postischemic hyperperfusion: pathophysiologic insights from positron emission tomography. J Cereb Blood Flow Metab. 1999; 19(5): 467-82.
87. Butcher KS, Lee SB, Parsons MW, et al. Differential prognosis of isolated cortical swelling and hypoattenuation on CT in acute stroke. Stroke. 2007; 38(3): 941-7.
88. Kidwell CS, Saver JL, Mattiello J, et al. Diffusion-perfusion MRI characterization of post-recanalization hyperperfusion in humans. Neurology. 2001; 57(11): 2015-21.
89. Murphy MJ, Tichauer KM, Sun L, Chen X, Lee TY. Mean transit time as an index of cerebral perfusion pressure in experimental systemic hypotension. Physiol Meas. Apr; 32(4): 395-405.
90. Davis SM, Donnan GA, Parsons MW, et al. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol. 2008; 7(4): 299-309.
91. Zaro-Weber O, Moeller-Hartmann W, Heiss WD, Sobesky J. Maps of time to maximum and time to peak for mismatch definition in clinical stroke studies validated with positron emission tomography. Stroke. Dec; 41(12): 2817-2821.
92. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995; 333(24): 1581-7.
93. Hacke W, Albers G, Al-Rawi Y, et al. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke. 2005; 36(1): 66-73.
94. Berger C, Fiorelli M, Steiner T, et al. Hemorrhagic transformation of ischemic brain tissue: asymptomatic or symptomatic? Stroke. 2001; 32(6): 1330-5.
95. Molina CA, Alvarez-Sabin J, Montaner J, et al. Thrombolysis-related hemorrhagic infarction: a marker of early reperfusion, reduced infarct size, and improved outcome in patients with proximal middle cerebral artery occlusion. Stroke. 2002; 33(6): 1551-6.
96. Hacke W, Donnan G, Fieschi C, et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet. 2004; 363(9411): 768-74.
97. Dzialowski I, Pexman JH, Barber PA, Demchuk AM, Buchan AM, Hill MD. Asymptomatic hemorrhage after thrombolysis may not be benign: prognosis by hemorrhage type in the Canadian alteplase for stroke effectiveness study registry. Stroke. 2007; 38(1): 75-9.
98. Thomalla G, Sobesky J, Kohrmann M, et al. Two tales: hemorrhagic transformation but not parenchymal hemorrhage after thrombolysis is related to severity and duration of ischemia: MRI study of acute stroke patients treated with intravenous tissue plasminogen activator within 6 hours. Stroke. 2007; 38(2): 313-8.
99. Montaner J, Molina CA, Monasterio J, et al. Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke. Circulation. 2003; 107(4): 598-603.
100. Demchuk AM, Morgenstern LB, Krieger DW, et al. Serum glucose level and diabetes predict tissue plasminogen activator-related intracerebral hemorrhage in acute ischemic stroke. Stroke. 1999; 30(1): 34-9.
101. Montaner J. Stroke biomarkers: can they help us to guide stroke thrombolysis? Drug News Perspect. 2006; 19(9): 523-32.
102. Selim M, Fink JN, Kumar S, et al. Predictors of hemorrhagic transformation after intravenous recombinant tissue plasminogen activator: prognostic value of the initial apparent diffusion coefficient and diffusion-weighted lesion volume. Stroke. 2002; 33(8): 2047-52.
103. Knauer C, Knauer K, Muller S, et al. A biochemical marker panel in MRI-proven hyperacute ischemic stroke-a prospective study. BMC Neurol. Mar 8; 12(1): 14.
104. Kawano H, Hirano T, Nakajima M, Inatomi Y, Yonehara T, Uchino M. Modified ASPECTS for DWI including deep white matter lesions predicts subsequent intracranial hemorrhage. J Neurol. Feb 17 2012. (in press).
105. Dankbaar JW, Hom J, Schneider T, et al. Dynamic perfusion CT assessment of the blood-brain barrier permeability: first pass versus delayed acquisition. AJNR Am J Neuroradiol. 2008; 29(9): 1671-6.
106. Lin K. Predicting transformation to type 2 parenchymal hematoma in acute ischemic stroke by CT permeability imaging. AJNR Am J Neuroradiol. Jun-Jul; 32(6): E124; author reply E125.
107. Sachdev P, Chen X, Wen W. White matter hyperintensities in mid-adult life. Curr Opin Psychiatry. 2008; 21(3): 268-74.
108. Murray AD, Staff RT, Shenkin SD, Deary IJ, Starr JM, Whalley LJ. Brain white matter hyperintensities: relative importance of vascular risk factors in nondemented elderly people. Radiology. 2005; 237(1): 251-7.
109. Laslo AM, Eastwood JD, Pakkiri P, Chen F, Lee TY. CT perfusion-derived mean transit time predicts early mortality and delayed vasospasm after experimental subarachnoid hemorrhage. AJNR Am J Neuroradiol. 2008; 29(1): 79-85.
110. Brilstra EH, Rinkel GJ, Algra A, van Gijn J. Rebleeding, secondary ischemia, and timing of operation in patients with subarachnoid hemorrhage. Neurology. 2000; 55(11): 1656-60.
111. Sloan MA, Haley Jr EC, Kassell NF, et al. Sensitivity and specificity of transcranial Doppler ultrasonography in the diagnosis of vasospasm following subarachnoid hemorrhage. Neurology. 1989; 39(11): 1514-8.
112. Reilly C, Amidei C, Tolentino J, Jahromi BS, Macdonald RL. Clot volume and clearance rate as independent predictors of vasospasm after aneurysmal subarachnoid hemorrhage. J Neurosurg. 2004; 101(2): 255-61.
113. Harrigan MR, Magnano CR, Guterman LR, Hopkins LN. Computed tomographic perfusion in the management of aneurysmal subarachnoid hemorrhage: new application of an existent technique. Neurosurgery. 2005; 56(2): 304-17. discussion 304-317.
114. Wintermark M, Ko NU, Smith WS, Liu S, Higashida RT, Dillon WP. Vasospasm after subarachnoid hemorrhage: utility of perfusion CT and CT angiography on diagnosis and management. AJNR Am J Neuroradiol. 2006; 27(1): 26-34.
115. Nogueira RG, Lev MH, Roccatagliata L, et al. Intra-arterial nicardipine infusion improves CT perfusion-measured cerebral blood flow in patients with subarachnoid hemorrhage-induced vasospasm. AJNR Am J Neuroradiol. 2009; 30(1): 160-4.
116. Broderick JP, Brott TG, Duldner JE, Tomsick T, Huster G. Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality. Stroke. 1993; 24(7): 987-93.
117. Sacco S, Marini C, Toni D, Olivieri L, Carolei A. Incidence and 10-year survival of intracerebral hemorrhage in a population-based registry. Stroke. 2009; 40(2): 394-9.
118. Sudlow CL, Warlow CP. Comparable studies of the incidence of stroke and its pathological types: results from an international collaboration. International Stroke Incidence Collaboration. Stroke. 1997; 28(3): 491-9.
119. van Asch CJ, Luitse MJ, Rinkel GJ, van der Tweel I, Algra A, Klijn CJ. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol. Feb; 9(2): 167-176.
120. Fewel ME, Thompson Jr BG, Hoff JT. Spontaneous intracerebral hemorrhage: a review. Neurosurg Focus. 2003; 15(4): E1. Oct 15.
121. Romero JM, Heit JJ, Delgado Almandoz JE, et al. Spot sign score predicts rapid bleeding in spontaneous intracerebral hemorrhage. Emerg Radiol. Jan 22.
122. Kidwell CS, Saver JL, Mattiello J, et al. Diffusion-perfusion MR evaluation of perihematomal injury in hyperacute intracerebral hemorrhage. Neurology. 2001; 57(9): 1611-7.
123. Fainardi E, Borrelli M, Saletti A, et al. CT perfusion mapping of hemodynamic disturbances associated to acute spontaneous intracerebral hemorrhage. Neuroradiology. 2008; 50(8): 729-40.
124. Rosand J, Eskey C, Chang Y, Gonzalez RG, Greenberg SM, Koroshetz WJ. Dynamic single-section CT demonstrates reduced cerebral blood flow in acute intracerebral hemorrhage. Cerebrovasc Dis. 2002; 14(3-4): 214-20.
125. Herweh C, Juttler E, Schellinger PD, Klotz E, Schramm P. Perfusion CT in hyperacute cerebral hemorrhage within 3 hours after symptom onset: is there an early perihemorrhagic penumbra? J Neuroimaging. Oct; 20(4): 350-353.
126. Butcher KS, Baird T, MacGregor L, Desmond P, Tress B, Davis S. Perihematomal edema in primary intracerebral hemorrhage is plasma derived. Stroke. 2004; 35(8): 1879-85.
127. Broderick JP, Diringer MN, Hill MD, et al. Determinants of intracerebral hemorrhage growth: an exploratory analysis. Stroke. 2007; 38(3): 1072-5.
128. Kazui S, Naritomi H, Yamamoto H, Sawada T, Yamaguchi T. Enlargement of spontaneous intracerebral hemorrhage. Incidence and time course. Stroke. 1996; 27(10): 1783-7.
129. Mayer SA, Brun NC, Begtrup K, et al. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2008; 358(20): 2127-37.
130. Mayer SA, Davis SM, Skolnick BE, et al. Can a subset of intracerebral hemorrhage patients benefit from hemostatic therapy with recombinant activated factor VII? Stroke. 2009; 40(3): 833-40.
131. Kim J, Smith A, Hemphill 3rd JC, et al. Contrast extravasation on CT predicts mortality in primary intracerebral hemorrhage. AJNR Am J Neuroradiol. 2008; 29(3): 520-5.
132. Wada R, Aviv RI, Fox AJ, et al. CT angiography "spot sign" predicts hematoma expansion in acute intracerebral hemorrhage. Stroke. 2007; 38(4): 1257-62.
133. Becker KJ, Baxter AB, Bybee HM, Tirschwell DL, Abouelsaad T, Cohen WA. Extravasation of radiographic contrast is an independent predictor of death in primary intracerebral hemorrhage. Stroke. 1999; 30(10): 2025-32.
134. Goldstein JN, Fazen LE, Snider R, et al. Contrast extravasation on CT angiography predicts hematoma expansion in intracerebral hemorrhage. Neurology. 2007; 68(12): 889-94.
135. Delgado Almandoz JE, Yoo AJ, Stone MJ, et al. The spot sign score in primary intracerebral hemorrhage identifies patients at highest risk of in-hospital mortality and poor outcome among survivors. Stroke. 2010; 41(1): 54-60.